3-(Aminomethyl)-5-bromopyridine

Catalog No.: 
ACWOLI452
CAS No.: 
135124-70-8
Molecular Formula: 
C6H7BrN2
Molecular Weight: 
187.04
3-(Aminomethyl)-5-bromopyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$99.00In stockIn stock
25g98%$410.00In stockIn stock
100g98%$1451.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Aminomethyl)-5-bromopyridine
IUPAC Name(5-bromopyridin-3-yl)methanamine
MDL No.MFCD06212876
Molecular FormulaC6H7BrN2
Molecular Weight187.04
SMILESNCC1=CC(Br)=CN=C1
InChI KeyOQUHYNMITHDQLD-UHFFFAOYSA-N
Synonym3-(Aminomethyl)-5-bromopyridine | (5-Bromo-3-pyridinyl)methylamine | 5-Bromo-3-pyridinemethylamine | 5-BROMO-3-PYRIDINEMETHANAMINE | 1-(5-BROMOPYRIDIN-3-YL)METHANAMINE | (5-Bromopyridin-3-yl)methanamine | MFCD06212876
CAS No.135124-70-8
PubChem CID22992264

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACWOLI452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWSYC714 route compound structure diagram
    ACWSYC71437669-64-0In Stock
  2. Then
  3. ACWOLI452 route product structure diagram
    ACWOLI452135124-70-8In Stock
Inquiry

2. ACWOLI452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJPUX285 route compound structure diagram
    ACJPUX28539741-46-3In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACWOLI452 route product structure diagram
    ACWOLI452135124-70-8In Stock
Inquiry

3. ACWOLI452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNPMO483 route compound structure diagram
    ACNPMO48335590-37-5In Stock
  2. Then
  3. ACWOLI452 route product structure diagram
    ACWOLI452135124-70-8In Stock
Inquiry

Comments (0)